Eurofins Agroscience Services purchased a global CRO Selcia

| By | Drug Development, Pharmaceutical Deal, R&D
0
564

Eurofins Agroscience Services, an agrochemical manufacturer, informed that it has acquired Selcia Limited, a global provider of custom radiolabelling and integrated drug discovery services.

Selcia is a global contract research provider of integrated drug discovery, medicinal chemistry and 14C radiolabeled compounds. Established in 2001, the company has two divisions: Selcia Discovery (focused on medicinal chemistry, biology) and Selcia Radiolabeling – one of the world’s largest supplier of custom 14C radiochemicals. Selcia produces custom radiolabelled compounds incorporating carbon-14 for the pharmaceutical, agrochemical, biotech, life sciences and chemical industries. These carbon-14 (14C) radiolabelled compounds are used to support a wide range of critical regulatory, REACH and research studies.

Selcia brings a profound knowledge, expertise and experience to the Agroscience division, further strengthening an already comprehensive offering of services to support regulatory submissions of agrochemicals and biocides.

Klaus Kuegler, Senior Vice President of Eurofins Agroscience Services Group, comments, “We are extremely pleased to welcome Selcia to the Eurofins Group. Selcia’s focus on quality, with GLP analytical and GMP 14C API manufacturing, and world leading 14C radiolabelling capabilities fills a strategic gap in Eurofins’ global offering in the highly attractive pharmaceutical and Agroscience testing markets. In addition, Selcia provides Eurofins with integrated drug discovery services with a track record of delivering preclinical candidates. We look forward to supporting Selcia’s growth by providing access to the full range of services and capabilities of the Eurofins Group.”

Eurofins Agroscience Services is a part of the Eurofins Scientific Group of companies. An international group of laboratories, Eurofins, headquartered in Bruxelles, provides testing and support services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins employs more than 30,000 employees across around 375 laboratories in 41 countries.

SOURCE: eurofins
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.